- Home
- FTEL vs LYEL Comparison
FTEL vs LYEL Comparison
Compare FTEL & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTEL
- LYEL
- Stock Information
- Founded
- FTEL 2007
- LYEL 2018
- Country
- FTEL Australia
- LYEL United States
- Employees
- FTEL N/A
- LYEL N/A
- Industry
- FTEL
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- FTEL
- LYEL Health Care
- Exchange
- FTEL Nasdaq
- LYEL Nasdaq
- Market Cap
- FTEL 207.1M
- LYEL 203.9M
- IPO Year
- FTEL 2023
- LYEL 2021
- Fundamental
- Price
- FTEL $0.91
- LYEL $0.70
- Analyst Decision
- FTEL
- LYEL Sell
- Analyst Count
- FTEL 0
- LYEL 2
- Target Price
- FTEL N/A
- LYEL $1.00
- AVG Volume (30 Days)
- FTEL 2.3M
- LYEL 1.3M
- Earning Date
- FTEL 03-28-2025
- LYEL 03-03-2025
- Dividend Yield
- FTEL N/A
- LYEL N/A
- EPS Growth
- FTEL N/A
- LYEL N/A
- EPS
- FTEL N/A
- LYEL N/A
- Revenue
- FTEL $4,466,775.00
- LYEL $63,000.00
- Revenue This Year
- FTEL N/A
- LYEL N/A
- Revenue Next Year
- FTEL N/A
- LYEL N/A
- P/E Ratio
- FTEL N/A
- LYEL N/A
- Revenue Growth
- FTEL N/A
- LYEL N/A
- 52 Week Low
- FTEL $0.63
- LYEL $0.51
- 52 Week High
- FTEL $49.50
- LYEL $3.26
- Technical
- Relative Strength Index (RSI)
- FTEL 25.90
- LYEL 64.48
- Support Level
- FTEL $0.87
- LYEL $0.57
- Resistance Level
- FTEL $1.42
- LYEL $0.63
- Average True Range (ATR)
- FTEL 0.99
- LYEL 0.05
- MACD
- FTEL -0.10
- LYEL 0.02
- Stochastic Oscillator
- FTEL 2.92
- LYEL 87.86
About FTEL Fitell Corporation
Fitell Corp engages in primary operations of selling gym and fitness equipment in Australia through its indirectly held wholly owned subsidiaries. It operates in two segments: online fitness equipment distribution and licensing business to service the large and growing boutique fitness sector of the broader health and fitness club industry. The majority fitness equipment business is conducted in Australia via its own e-commerce platform and, through third-party sites. Licensing service offers a turnkey solution for personal training studios and commercial gym chains. The company earns maximum of revenue for retail.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.